Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 667, P. 91 - 100
Published: April 10, 2024
Language: Английский
Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 667, P. 91 - 100
Published: April 10, 2024
Language: Английский
Small, Journal Year: 2023, Volume and Issue: 20(3)
Published: Sept. 12, 2023
Abstract Artificial enzymes, as alternatives to natural have attracted enormous attention in the fields of catalysis, biosensing, diagnostics, and therapeutics because their high stability low cost. Polyoxometalates (POMs), a class inorganic metal oxides, recently shown great potential mimicking enzyme activity due well‐defined structure, tunable composition, catalytic efficiency, easy storage properties. This review focuses on recent advances POM‐based artificial enzymes. Different types POMs derivatives‐based mimetic functions are covered, well corresponding mechanisms (where available). An overview broad applications representative enzymes from biosensing theragnostic is provided. Insight into current challenges future directions for POMs‐based discussed.
Language: Английский
Citations
18Journal of Colloid and Interface Science, Journal Year: 2023, Volume and Issue: 654, P. 212 - 223
Published: Oct. 11, 2023
Language: Английский
Citations
18Small, Journal Year: 2024, Volume and Issue: 20(26)
Published: Jan. 23, 2024
Nanozyme-based metabolic regulation triggered by tumor-specific endogenous stimuli has emerged as a promising therapeutic strategy for tumors. The current efficacy, however, is constrained the limited concentration of substrates and plasticity Consequently, implementation efficient in tumor therapy urgently needed. Herein, versatile nanozyme-based nicotinamide adenine dinucleotide (NADH) circulating oxidation nanoreactor reported. First, synthesized cobalt-doped hollow carbon spheres (Co-HCS) possess NADH oxidase (NOX)-mimicking activity to disrupt oxidative phosphorylation (OXPHOS) pathway cells. Second, substrate-cycle manner Co-HCS can be used overcome limitation substrate deficiency. Finally, 2-Deoxy-D-glucose (2-DG) 6-aminonicotinamide (6-AN) are introduced block glycolysis pentose phosphate (PPP), thus creating (Co-HCS/D/A) through triple cellular metabolism disruption. In vitro vivo results demonstrate that designed not only enhances catalytic efficiency but also disrupts homeostasis, leading outcome. This study develops novel disruption, which addresses limitations therapy.
Language: Английский
Citations
8Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 500, P. 157299 - 157299
Published: Nov. 1, 2024
Language: Английский
Citations
8Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 667, P. 91 - 100
Published: April 10, 2024
Language: Английский
Citations
7